UVM Cancer Center members and trainees attend ASCO 2023

April 12, 2023 by Kate Strotmeyer

Source: Creative Commons

The American Society of Clinical Oncology will convene for its annual meeting from June 2-6 in Chicago, IL. Congratulations to the following UVM Cancer Center members and trainees who were invited to share their research findings:

Poster Discussions

 

Session Title: Prevention, Risk Reduction, and Hereditary Cancer
Session Date and Time:  6/3/2023, 1:15 PM-4:15 PM

Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients. 

Kara K. Landry, Michael DeSarno, Lindsay Kipnis, Farid Barquet Ramos, Katelyn Breen, Kaleigh Patton, Audrey Morrissette, Ryan Buehler, Chinedu Ukaegbu, Mersedeh Rohanizadegan, Matthew B. Yurgelun, Sapna Syngal, Huma Q. Rana, Judy Ellen Garber; 

_____

Session Title: Professional development and educational advances
Session date and time:  6/4/23, 8am to 11am, 
Poster discussion date and time: 6/4/23, 11:30am to 1pm

Assessment of YouTube as an information source for Immune checkpoint inhibitors therapy.

Tulika Garg, Rutvi Chahal, Atulya Khosla, Rohit Singh, Karan Jatwani

Posters

 

Session Title: Developmental therapeutics - Immunotherapy
Session date: 6/3/23, 8am to 11am

Retrospective analysis on association of ABO blood type and ICIs responses.

Akshee Batra, Rohit Singh, Samantha Schuetz, Helen Gandler, Derek Devine, Hibba Rehman, Shahid Ahmed. 

_____

Session Title: Prevention, Risk Reduction, and Hereditary Cancer
Session Date and Time:  6/3/2023, 1:15 PM-4:15 PM

Eliminating barriers to uptake of germline genetic testing for patients with advanced cancer: The GTAC study.

Kara K. LandryHeather M Feldman, Sarah A NowakHannah L Taylor, Marie Johns, Wendy McKinnonLaura S Colello, Sarah M. Nielsen, Edward D. Esplin, Marc Greenblatt, Marie Wood

_____

Session Title: Health services research and quality improvement
Session date: 6/3/23, 1:15pm to 4:15pm

Effect of concomitant gut-microbiome altering medications on ICIs; A retrospective study.

Rohit SinghAkshee BatraSamantha SchuetzHelen GandlerDerek DevineHibba RehmanShahid Ahmed

_____

Session Title: Professional development and educational advances
Session date and time:  6/4/23, 8am to 11am

Characterizing imposter syndrome among oncologists on social media. Eleonora Teplinsky, Sara Beltran Ponce, Don S Dizon, Narjust Florez, Matthew S Katz, Lindsey McAlarnen, Scott Moerdler, Martina Murphy, Hina Saeed, Maura Barry.

Online abstracts:

 

1. Okado I, Liu M, Elhajj C, Wilkens L, Holcombe RF. Rural cancer care delivery during the COVID-19 pandemic for patients with early-stage cancer.  Proc ASCO, 2023; e18566. 

2. Chahal R, Garg T, Khosla A, Jatwani K, Singh R. Quality assessment of information on chimeric antigen receptor T-cell therapy on YouTube: An analysis. Proc ASCO, 2023; 13633

3. Thomas R, Searles S, Hitt J, Kennedy A, Jasra S - Disparities in fertility preservation in rural adolescent and young adult patients with hematologic malignancies. Proc ASCO, 2023; e18764.